Evidence map›Paper›PMID 17459921›Full record

ArticleJournal of virology2007

Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation.

Amy Baker, Kent J Rohleder, Les A Hanakahi, Gary Ketner

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 160 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Virus Infection and mRNA Nuclear Export.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Early Nuclear Events after Herpesviral Infection.Journal of clinical medicine · 2019
    Review

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Amy BakerW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA.
Kent J Rohleder
Les A Hanakahi
Gary Ketner
Johns Hopkins University · US

Funding

Training: Molecular & Cellular Bases of Infectious DiseasesT32AI007417 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall · 1994 to 2026
$11.9M
Predoctoral Training Program in Human GeneticsT32GM007814 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 1985 to 2021
$10.6M
DOUBLE STRAND BREAK REPAIR--INHIBITION BY ADENOVIRUS E4R01CA082127 · NCI · JOHNS HOPKINS UNIVERSITY · PI KETNER, GARY W · 2001 to 2005
$1.2M
MOLECULAR MECHANISMS OF NHEJ IN MAMMALIAN CELLSR01GM070639 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI HANAKAHI, LESLYN A · 2004 to 2008
$1.2M
NCI NIH HHS 1R01 CA/GM82127NIAID NIH HHS T32 AI007417NIGMS NIH HHS 1R01 GM070639-1NIGMS NIH HHS R01 GM070639NIGMS NIH HHS T32 GM007814
6 · The paper itself

Abstract

Cells infected by adenovirus E4 mutants accumulate end-to-end concatemers of the viral genome that are assembled from unit-length viral DNAs by nonhomologous end joining (NHEJ). Genome concatenation can be prevented by expression either of E4 11k (product of E4orf3) or of the complex of E4 34k (product of E4orf6) and E1b 55k. Both E4 11k and the E4 34k/E1b 55k complex prevent concatenation at least in part by inactivation of the host protein Mre11: E4 11k sequesters Mre11 in aggresomes, while the E4 34k/E1b 55k complex participates in a virus-specific E3 ubiquitin ligase that mediates ubiquitination and proteasomal degradation. The E4 34k/E1b 55k complex, but not E4 11k, also inhibits NHEJ activity on internal breaks in the viral genome and on V(D)J recombination substrate plasmids, suggesting that it may interfere with NHEJ independently of its effect on Mre11. We show here that DNA ligase IV, which performs the joining step of NHEJ, is degraded as a consequence of adenovirus infection. Degradation is dependent upon E4 34k and E1b 55k, functional proteasomes, and the activity of cellular cullin 5, a component of the adenoviral ubiquitin ligase. DNA ligase IV also interacts physically with E1b 55k. The data demonstrate that DNA ligase IV, like Mre11, is a substrate for the adenovirus-specific E3 ubiquitin ligase; identify an additional viral approach to prevention of genome concatenation; and provide a mechanism for the general inhibition of NHEJ by adenoviruses.

Indexed as

AdenoviridaeAdenoviridae InfectionsAdenovirus E1B ProteinsAdenovirus E4 ProteinsCell Line, TumorDNA-Binding ProteinsDNA BreaksDNA, ConcatenatedDNA Ligase ATPDNA LigasesDNA, ViralGenome, ViralHumansMRE11 Homologue ProteinProteasome Endopeptidase ComplexProtein Processing, Post-TranslationalAdenovirus E1B ProteinsAdenovirus E4 ProteinsDNA-Binding ProteinsDNA, ConcatenatedDNA Ligase ATPDNA LigasesDNA, ViralLIG4 protein, humanMRE11 Homologue ProteinMRE11 protein, humanProteasome Endopeptidase ComplexUbiquitin-Protein Ligases

Identifiers

PMID17459921
PMCPMC1933317
OpenAlexW2123019823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.